Glenmark PharmaceuticalsGLENMARK 
$20.910.33%24h
0.33%24h
Global rank2457
Market cap$5.90B
Change 7d3.00%
YTD Performance105.35%
SP500 benchmarkOutperform
P/E1.99
P/S3.89
Revenue$1.52B
Earnings$44.99M
Dividend yield-
Main Sector
Healthcare
Glenmark Pharmaceuticals (GLENMARK) Cash on Hand
GLENMARK Cash on Hand in 2022: $174.46M
According to Glenmark Pharmaceuticals latest financial reports the cash on hand of GLENMARK is $174.46M, an increase of 1.39% to 2022. At the end of 2022 company had $172.07M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
GLENMARK Cash on Hand History from 2019 to 2023
-
Value:-
GLENMARK Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $174.46M | 1.39% |
| 2022 | $172.07M | 18.85% |
| 2021 | $144.78M | 2.93% |
| 2020 | $140.66M | 4.13% |
| 2019 | $135.09M | - |
View the Top Cash on Hand Companies 
